We are live on ! Find out more
ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of ADMS yet.

ADMS Hedge Fund Activity: Q4 2021 in Review

0 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Adamas Pharmaceuticals (ADMS) for Q4 2021, worth a combined $0 — down 100% from $148M a quarter earlier.

Sellers outnumbered buyers: 62 funds closed out of ADMS and 0 opened new positions — a net loss of 62 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $26.8M sold.

  • 0 institutional investors held Adamas Pharmaceuticals (ADMS) as of Q4 2021, down from 63 in Q3 2021.
  • Funds reported $0 of Adamas Pharmaceuticals stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Adamas Pharmaceuticals positions in Q4 2021 and 62 closed out, a net change of -62 holders.
  • The largest Adamas Pharmaceuticals seller in Q4 2021 was Fidelity Investments, an estimated $26.8M sold.

Based on aggregated 13F filings for Q4 2021.